Ahmad Tareq

Dr. Ahmad Hussen Tareq is a distinguished professional in the field of pharmaceutical sciences, holding a Pharm.D. degree with distinction and a Ph.D. focused on antimicrobial resistance.

He is renowned for his groundbreaking work in developing the 'Teixobactin' antibiotic, which targets a range of healthcare challenges including antimicrobial resistance and drug-resistant infections like MRSA, VRE, and MDR-TB.

With expertise spanning infectious diseases, antimicrobial resistance research, clinical trials, and global health regulations, he plays a pivotal role in advising the health ministry of a low middle-income country on various health-related issues.

Dr. Tareq's contributions extend beyond academia, as he has been actively involved in the development of clinical and lab standards through his role as secretary and technical contributor to a global standards development body known as CLSI.

His innovative approaches include the creation of two antibiotic platforms combating superbugs, advancements in the revival of activity in drug-resistant antibiotics such as a potent version of Vancomycin, and the significant discovery of Teixobactin.

Additionally, he has pioneered mass spectrometric techniques for rapid microbial diagnostics and various other applications, revolutionizing the field with methods that are faster and more accurate than traditional approaches.

Having received training from a Nobel laureate group in protein engineering, Dr. Tareq has led multiple projects in areas such as antimicrobial resistance, cancer research, and malnutrition, ensuring compliance with stringent regulatory standards.

His experience includes collaborations with prestigious institutions like MIT, where he engaged in infectious diseases research and trained post-doctoral scholars. Dr. Tareq's commitment to knowledge transfer is evident through his teaching endeavors, reaching thousands of students and researchers globally.

Moreover, his tenure within the Singapore government's technology ecosystem underscores his dedication to addressing critical issues like antimicrobial resistance monitoring, hospital-acquired infections prevention, digital healthcare, and public health strategies.

Dr. Ahmad Hussen Tareq's diverse professional background includes roles as a mentor at MIT COVID-19 challenge, advisor to startups, and involvement with entrepreneurial incubators like Antler and Entrepreneur First. He continues to contribute significantly to the advancement of pharmaceutical sciences and global health initiatives.